References
- JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
- RenFShenJShiHHornicekFJKanQDuanZNovel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancerBiochim Biophys Acta20161866226627527717733
- CannistraSACancer of the ovaryN Engl J Med2004351242519252915590954
- DengJWangLChenHTargeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancerOncotarget2016734557715578827304054
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- CakmakogluBAAttarRKahramanOTCyclooxygenase-2 gene and epithelial ovarian carcinoma riskMol Biol Rep20113853481348621107726
- BaldwinLAHuangBMillerRWTen-year relative survival for epithelial ovarian cancerObstet Gynecol2012120361261822914471
- QinDWangWLeiHCDDO-Me reveals USP7 as a novel target in ovarian cancer cellsOncotarget2016747770967710927780924
- VaughanSCowardJIBastRCJrRethinking ovarian cancer: recommendations for improving outcomesNat Rev Cancer2011111071972521941283
- QinDJTangCXYangLHsp90 is a novel target molecule of CDDO-Me in inhibiting proliferation of ovarian cancer cellsPLoS One2015107e013233726134508
- BanerjeeSKayeSBNew strategies in the treatment of ovarian cancer: current clinical perspectives and future potentialClin Cancer Res201319596196823307860
- HauDKGambariRWongRSPhyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: involvement of cytochrome P450 CYP2E1Phytomedicine200916875176019386480
- ShenZQDongZJPengHLiuJKModulation of PAI-1 and tPA activity and thrombolytic effects of corilaginPlanta Med200369121109111214750026
- SudjaroenYHullWEErbenGIsolation and characterization of ellagitannins as the major polyphenolic components of longan (Dimocarpus longan Lour) seedsPhytochemistry20127722623722277734
- OkabeSSuganumaMImayoshiYTaniguchiSYoshidaTFujikiHNew TNF-α releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, megusurinokiBiol Pharm Bull200124101145114811642320
- DuanWYuYZhangLAntiatherogenic effects of Phyllanthus emblica associated with corilagin and its analogueYakugaku Zasshi2005125758759115997216
- ChengJTLinTCHsuFLAntihypertensive effect of corilagin in the ratCan J Physiol Pharmacol19957310142514298748933
- DuanWGShenZQYanMYunYZhangLYCorilagin, a promising natural product to treat cardiovascular diseasesSinghVKMishraSKGovilJNPhytopharmacology and Therapeutic Values IIHoustonStudium Press2008163172
- KinoshitaSInoueYNakamaSIchibaTAniyaYAntioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilaginPhytomedicine2007141175576217293097
- HauDKZhuGYLeungAKIn vivo anti-tumour activity of corilagin on HEP3B hepatocellular carcinomaPhytomedicine2010181111521036022
- GambariRHauDKWongWYChuiCHSensitization of HEP3B hepatoma cells to cisplatin and doxorubicin by corilaginPhytother Res201428578178323913631
- MingYZhengZChenLCorilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrestCell Biol Int201337101046105423686743
- MuresanXMCervellatiFSticozziCThe loss of cellular junctions in epithelial lung cells induced by cigarette smoke is attenuated by corilaginOxid Med Cell Longev2015201563175825802682
- WangZGuoQYZhangXJCorilagin attenuates aerosol bleomycin-induced experimental lung injuryInt J Mol Sci20141569762977924886817
- JiaLJinHZhouJA potential anti-tumor herbal medicine, corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathwaysBMC Complement Altern Med2013133323410205